驯服猛虎:超大剂量硝酸甘油治疗交感神经崩溃性急性肺水肿
本文报告1例60岁男性无既往合并症的SCAPE患者,表现为急性严重呼吸困难、极度出汗、烦躁、焦虑、心悸,查体低氧、高血压、严重呼吸急促和心动过速,双肺弥漫湿啰音,床旁超声双肺各区B-profile、下腔静脉可塌陷>50%。给予无创通气和超大剂量硝酸甘油(9 mg静脉推注联合76 mg输注,为文献中最高剂量),患者数小时内改善、不再需要吸氧,急诊观察数小时后离院。作者认为这是首例描述超大剂量推注/最高剂量及延长高剂量输注联合无创通气安全有效治疗SCAPE、避免机械通气和死亡的报告,并认为高剂量静脉硝酸甘油对SCAPE患者极其有效且安全。
要点
- SCAPE的核心病理生理特征是全身血管收缩和高血压导致的病理性后负荷升高,治疗重点从利尿剂转向血管扩张剂(尤其高剂量硝酸盐)联合无创正压通气。
- 硝酸甘油低剂量(10-20 μg/min)降低前负荷,高剂量(>100 μg/min)通过动脉扩张降低后负荷,主要目标是尽早降低后负荷以打断交感神经突然激活所致的恶性循环。
- 本例为60岁男性无既往合并症,急诊表现为急性严重呼吸困难伴极度出汗、烦躁、焦虑、心悸,低氧、高血压、严重呼吸急促和心动过速,双肺弥漫湿啰音。
- 床旁超声显示双肺各区B-profile、下腔静脉可塌陷>50%;治疗为无创通气联合9 mg静脉推注硝酸甘油及76 mg输注(文献最高剂量)。
- 患者数小时内改善、不再需要吸氧,急诊观察数小时后离院;作者认为这是首例报告超大剂量推注/最高剂量及延长高剂量输注联合无创通气安全有效治疗SCAPE。
适用人群与场景
- SCAPE患者,表现为急性严重呼吸困难、极度出汗、烦躁、焦虑、心悸,低氧、高血压、严重呼吸急促和心动过速,双肺弥漫湿啰音,床旁超声双肺各区B-profile、下腔静脉可塌陷>50%。
- SCAPE患者可能等容量、低容量或高容量,问题在于液体向肺内转移而非高血容量。
诊断标准与关键阈值
- 床旁超声显示双肺各区B-profile,下腔静脉可塌陷>50%。
处置流程与药物剂量
- 给予无创通气。
- 给予硝酸甘油9 mg静脉推注,联合76 mg输注(原文未写明输注时长和输注速度)。
- 硝酸甘油低剂量(10-20 μg/min)降低前负荷,高剂量(>100 μg/min)通过动脉扩张降低后负荷;主要目标是尽早降低后负荷。
- 治疗重点从利尿剂转向血管扩张剂(尤其高剂量硝酸盐)联合无创正压通气。
红旗征与不能漏的情况
- 急性严重呼吸困难伴极度出汗、烦躁、焦虑、心悸,低氧、高血压、严重呼吸急促和心动过速,双肺弥漫湿啰音。
研究设计与关键结果
- 本文为病例报告:1例60岁男性无已知既往合并症,因急性起病严重呼吸困难就诊,伴极度出汗、烦躁、焦虑、心悸;查体低氧、高血压、严重呼吸急促和心动过速,双肺各区弥漫湿啰音;床旁超声双肺各区B-profile,下腔静脉可塌陷>50%。
- 给予无创通气和超大剂量硝酸甘油(9 mg静脉推注联合76 mg输注,为文献中最高剂量),患者数小时内改善,不再需要吸氧,急诊观察数小时后离院。
- 作者认为这是首例描述超大剂量推注/最高剂量及延长高剂量输注联合无创通气安全有效治疗SCAPE、避免机械通气和死亡的报告。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为高剂量静脉硝酸甘油对SCAPE患者极其有效且安全,超大剂量推注/最高剂量及延长高剂量输注联合无创通气可避免机械通气和死亡。
- SCAPE治疗重点从利尿剂转向血管扩张剂(尤其高剂量硝酸盐)联合无创正压通气。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Sympathetic Crashing Acute Pulmonary Edema (SCAPE) lies on the end of the acute heart failure syndrome spectrum with pulmonary edema in all lung zones. NTG at lower doses (10-20 μg/min) cause preload reduction, and at higher doses (> 100 μg/min) causes after-load reduction by arterial dilatation. The main aim is to decrease the afterload at the earliest to cut the vicious cycle caused by sudden sympathetic upsurge. To our knowledge, this is the highest nitroglycerin dose usage in the literature.
CASE: A 60-year-old male with no known prior co-morbidities presented to our Emergency with complaints of acute onset severe shortness of breath, which was also associated with extreme diaphoresis, agitation, anxiety, and palpitations. On Examination, the patient was hypoxic and hypertensive with severe tachypnea and tachycardia. On Auscultation, diffuse bilateral crackles in all areas were heard. Point of care ultrasound showed bilateral B-profile in all lung zones, inferior vena cava was >50% collapsible. We managed the patient with non-invasive ventilation and ultrahigh dose nitroglycerin/ highest ever- 9 mg intravenous bolus with 76 mg infusion. The patient had improved within hours and did not require oxygen. The patient was discharged from the emergency after a few hours of observation.
DISCUSSION: SCAPE occurs due to a vicious spiral involving increasing sympathetic outflow, excessive afterload, and worsening heart failure. The central, defining pathophysiological feature of SCAPE is pathologically elevated afterload due to systemic vasoconstriction and hypertension. SCAPE patients may be euvolemic, hypovolemic or hypervolemic. The problem is shift of fluid into the lungs rather than hypervolemia. The emphasis on treating pulmonary edema has shifted from diuretics to vasodilators, especially high-dose nitrates, combined with non-invasive positive pressure ventilation.
CONCLUSION: This is the first report describing the safe and effective administration of ultra-high dose bolus/ highest dose ever and prolonged high-dose infusion for SCAPE, along with Non-invasive ventilation, which has prevented mechanical ventilation and mortality. High doses of intravenous NTG are extremely effective and safe for SCAPE patients.
参考来源
- Siddiqua N, Bhaskararayuni J, Sahu AK, et al. Taming the Tiger: Ultra high dose nitroglycerin in managing sympathetic crashing acute pulmonary edema patient. Am J Emerg Med. 2023. PMID: 37002114. doi:10.1016/j.ajem.2023.03.043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。